Skincubator Neocare

Company Overview

Snapshot

Founded in August 2022, Skincubator Neocare operates with 1–10 employees, developing a wearable incubator for preterm infants.

Business overview

Skincubator Neocare is a Health Tech & Life Sciences company focused on developing medical devices for neonatal care. The company's core product is a wearable incubator designed specifically for preterm infants during their critical first days and weeks. This solution aims to facilitate complete skin-to-skin care while addressing clinical, technical, and behavioral challenges within Neonatal ICUs, serving the healthcare and patient markets.

Company Intelligence Q&A

What is Skincubator Neocare's primary focus?

Skincubator Neocare is developing the world's first wearable incubator, specifically designed for preterm infants in their initial days and weeks of life. This technology aims to enable complete skin-to-skin care while addressing various challenges in the Neonatal ICU.

When was Skincubator Neocare founded?

Skincubator Neocare was founded in August 2022.

What significant funding did Skincubator Neocare receive in June 2025?

This non-equity funding supports the company's development of its wearable incubator technology.

What problem does Skincubator Neocare's product aim to solve?

The company's wearable incubator solution addresses key clinical, technical, and behavioral challenges in the Neonatal ICU, enabling complete skin-to-skin care for the tiniest preterm infants.

What is the current product stage of Skincubator Neocare's technology?

Skincubator Neocare's wearable incubator is currently in the R&D product stage. The company is actively developing and refining its technology, aiming to bring this innovative solution for preterm infant care to market in the future. This stage involves extensive research, prototyping, and testing to ensure the device meets the necessary clinical and safety standards.